| # | Drug | Count |
|---|---|---|
| 0 | ECULIZUMAB | 9 |
| 1 | OMEPRAZOLE | 9 |
| 2 | OMEPRAZOLE MAGNESIUM | 9 |
| 3 | RIBOCICLIB | 8 |
| 4 | ERGOCALCIFEROL | 7 |
| 5 | ALBUTEROL SULFATE | 6 |
| 6 | LETROZOLE | 5 |
| 7 | MEPOLIZUMAB | 5 |
| 8 | PREDNISONE | 5 |
| 9 | GABAPENTIN | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 2 | 0.0057 |
| 1 | ASIAN GINSENG | 1 | 0.0024 |
| 2 | BEVACIZUMAB-BVZR | 1 | 0.0014 |
| 3 | ONASEMNOGENE ABEPARVOVEC-XIOI | 2 | 0.0009 |
| 4 | PSYLLIUM HUSK | 1 | 0.0007 |
| 5 | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | 1 | 0.0006 |
| 6 | CAPLACIZUMAB | 1 | 0.0006 |
| 7 | METHYLCELLULOSE | 1 | 0.0004 |
| 8 | VINORELBINE | 2 | 0.0003 |
| 9 | CHLORAMBUCIL | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 4 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 5 | Complement Inhibitor [EPC] | 9 | 0.0002 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 7 | Estrogen Receptor Antagonist [EPC] | 3 | 0.0001 |
| 8 | Aromatase Inhibitor [EPC] | 6 | 0.0001 |
| 9 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 1 | 0.0000 |